Published 7:52 am Monday, November 2, 2026
For patients living with rare diseases, hope depends on discoveries that have not happened yet. That is why Congress should pass the Maintaining Investments in New Innovation, or MINI Act. The bipartisan legislation would help preserve investment in genetically targeted technologies, giving researchers a stronger foundation to pursue the next generation of treatments for patients who are still waiting for answers.
I know what it means to wait.
For nearly a year, my health declined without anyone understanding why. I lost 35 pounds in three months. Neuropathy spread through my body. My kidneys were not functioning, and my heart problems left me too fatigued to do much of anything.…